Diabetes in People with HIV.
Diabetes in People with HIV.
复制标题
DOI：
10.1007/s11892-021-01382-8
复制
发表时间：
2021-03-17
影响因子：
4.2
通讯作者：
Brown TT
中科院分区：
文献类型：
--
作者：
Sarkar S;Brown TT
讨论艾滋病毒感染者（PWH）糖尿病的诊断、治疗和并发症，并回顾可能导致糖尿病发展或改变PWH伴糖尿病护理和治疗决策的艾滋病毒相关因素。对于患有动脉粥样硬化性心血管疾病、心力衰竭和/或慢性肾脏疾病的患者，应考虑使用GLP-1受体激动剂和SGLT-2抑制剂。然而，这一建议的证据是基于未在仅由PWH组成的人群中进行的研究。糖尿病是PWH的一种重要合并症，增加了他们已经增加的心血管疾病风险。应评估艾滋病毒特异性因素，包括抗逆转录病毒治疗与治疗糖尿病和/或预防心血管疾病药物的相互作用。
To discuss the diagnosis, treatment, and complications of diabetes in people with HIV (PWH) and to review HIV-related factors that may contribute to the development of diabetes or alter decisions in the care and treatment of PWH with diabetes. For those patients with atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease, GLP-1 receptor agonists and SGLT-2 inhibitors should be considered for use. Evidence for this recommendation is, however, based on studies that were not conducted in populations consisting solely of PWH. Diabetes is a significant comorbidity in PWH and adds to their already heightened risk of cardiovascular disease. HIV-specific factors, including interactions of antiretroviral therapy with medications that either treat diabetes and/or prevent cardiovascular disease, should be evaluated.
登录
查看更多内容
影响因子：
16.2
作者：
通讯作者：
--
影响因子：
--
作者：
Brown, TT;Cole, SR;Dobs, AS
通讯作者：
Dobs, AS
影响因子：
168.9
作者：
Dormandy, JA;Charbonnel, B;Taton, J
通讯作者：
Taton, J
影响因子：
11.8
作者：
Dube, Michael P.;Chan, Ellen S.;Yarasheski, Kevin E.
通讯作者：
Yarasheski, Kevin E.
DOI：
10.1007/s13300-017-0273-4
发表时间：
2017-08
期刊：
Diabetes therapy : research, treatment and education of diabetes and related disorders
影响因子：
--
作者：
Filipova E;Uzunova K;Kalinov K;Vekov T
通讯作者：
Vekov T